Synapse - Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results

Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results Meeting Abstract

Authors:	Sternschuss, M.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Goh, A. C.; Cha, E. K.; Donat, S. M.; Hakimi, A. A.; Matulewicz, R.; Funt, S. A.; Bajorin, D. F.; Iyer, G.; Ostrovnaya, I.; Al-Ahmadie, H. A.; Rosenberg, J. E.; Coleman, J.; Teo, M. Y.
Abstract Title:	Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results
Meeting Title:	2024 ASCO Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	4 Suppl.
Meeting Dates:	2024 Jan 25-27
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-02-01
Language:	English
ACCESSION:	WOS:001266676900241
DOI:	10.1200/JCO.2024.42.4_suppl.645
PROVIDER:	wos
Notes:	Meeting Abstract: 645 -- Source: Wos